Laboratory of America Holdings (LH) Touches $183.27 High on May, 25; Healthcare Services Group, Inc. (HCSG) Had 1 Analysts Last Week

May 25, 2018 - By Robert Davis

Laboratory Corporation of America Holdings (NYSE:LH) Logo

The stock of Laboratory Corporation of America Holdings (NYSE:LH) reached all time high today, May, 25 and still has $197.93 target or 8.00% above today’s $183.27 share price. This indicates more upside for the $18.75B company. This technical setup was reported by Barchart.com. If the $197.93 PT is reached, the company will be worth $1.50B more. The stock increased 4.48% or $7.865 during the last trading session, reaching $183.265. About 526,098 shares traded. Laboratory Corporation of America Holdings (NYSE:LH) has risen 14.17% since May 25, 2017 and is uptrending. It has outperformed by 2.62% the S&P500.

Among 4 analysts covering Healthcare Services (NASDAQ:HCSG), 1 have Buy rating, 0 Sell and 3 Hold. Therefore 25% are positive. Healthcare Services had 19 analyst reports since July 29, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Wednesday, October 18 by Jefferies. The firm earned “Buy” rating on Tuesday, October 17 by Stifel Nicolaus. Robert W. Baird downgraded Healthcare Services Group, Inc. (NASDAQ:HCSG) on Wednesday, February 7 to “Hold” rating. Jefferies maintained Healthcare Services Group, Inc. (NASDAQ:HCSG) on Monday, August 21 with “Hold” rating. As per Tuesday, April 17, the company rating was maintained by Jefferies. The rating was maintained by Credit Suisse on Wednesday, April 18 with “Outperform”. The rating was maintained by Jefferies with “Hold” on Thursday, September 28. The firm has “Outperform” rating by Robert W. Baird given on Friday, September 16. The firm has “Buy” rating given on Tuesday, August 22 by Robert W. Baird. The stock has “Outperform” rating by Credit Suisse on Friday, November 3. See Healthcare Services Group, Inc. (NASDAQ:HCSG) latest ratings:

17/04/2018 Broker: Jefferies Rating: Hold New Target: $40.0000 Maintain
18/04/2018 Broker: Credit Suisse Old Rating: Outperform New Rating: Outperform Old Target: $62 New Target: $48 Maintain
18/04/2018 Broker: Stifel Nicolaus Old Rating: Buy New Rating: Hold Old Target: $50 Downgrade
16/04/2018 Broker: Robert W. Baird Rating: Hold New Target: $48.0000 Maintain
07/02/2018 Broker: Robert W. Baird Rating: Hold New Target: $50.0 Downgrade

More recent Healthcare Services Group, Inc. (NASDAQ:HCSG) news were published by: Nasdaq.com which released: “3 Top Healthcare Stocks to Buy Right Now” on May 01, 2018. Also Globenewswire.com published the news titled: “Consolidated Research: 2018 Summary Expectations for Virtusa, AutoZone, Healthcare Services Group, Vmware …” on May 17, 2018. Fool.com‘s news article titled: “The 3 Stocks on the MFM Team’s Radar” with publication date: May 17, 2018 was also an interesting one.

Since March 16, 2018, it had 0 insider buys, and 2 selling transactions for $156,725 activity. $89,000 worth of Healthcare Services Group, Inc. (NASDAQ:HCSG) shares were sold by MOSS ROBERT J. Shares for $67,725 were sold by Ottaviano Dino D.

The stock increased 1.06% or $0.39 during the last trading session, reaching $37.1. About 186,329 shares traded. Healthcare Services Group, Inc. (NASDAQ:HCSG) has risen 0.69% since May 25, 2017 and is uptrending. It has underperformed by 10.86% the S&P500.

Healthcare Services Group, Inc. provides management, administrative, and operating services to the housekeeping, laundry, linen, facility maintenance, and dietary service departments to nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States. The company has market cap of $2.74 billion. It operates through two divisions, Housekeeping and Dietary. It has a 31.18 P/E ratio. The Housekeeping segment engages in the cleaning, disinfecting, and sanitizing of resident rooms and common areas of clientÂ’s facility, as well as laundering and processing of the bed linens, uniforms, resident personal clothing, and other assorted linen items utilized at a client facility.

Investors sentiment decreased to 1.26 in 2017 Q4. Its down 0.07, from 1.33 in 2017Q3. It worsened, as 13 investors sold Healthcare Services Group, Inc. shares while 85 reduced holdings. 34 funds opened positions while 89 raised stakes. 68.88 million shares or 4.32% more from 66.03 million shares in 2017Q3 were reported. Moreover, Fuller & Thaler Asset Mgmt has 0.02% invested in Healthcare Services Group, Inc. (NASDAQ:HCSG). Peapack Gladstone invested 0.02% in Healthcare Services Group, Inc. (NASDAQ:HCSG). Ranger Investment Mgmt Lp has invested 0.02% in Healthcare Services Group, Inc. (NASDAQ:HCSG). Legacy Partners has 0.31% invested in Healthcare Services Group, Inc. (NASDAQ:HCSG) for 11,700 shares. Massachusetts Svcs Ma invested in 978,571 shares. Arizona State Retirement stated it has 0.06% in Healthcare Services Group, Inc. (NASDAQ:HCSG). Overbrook Mgmt holds 0.06% or 5,850 shares. Comerica Bankshares reported 0.04% in Healthcare Services Group, Inc. (NASDAQ:HCSG). Proshare Advsrs Limited Liability Corporation holds 0.06% or 169,345 shares in its portfolio. Evercore Wealth Mgmt Ltd Llc holds 320 shares. Moreover, Polen Cap Mngmt Limited Liability has 0% invested in Healthcare Services Group, Inc. (NASDAQ:HCSG). First Mercantile Trust accumulated 12,226 shares or 0.13% of the stock. Bb&T reported 0.01% in Healthcare Services Group, Inc. (NASDAQ:HCSG). North Carolina-based State Bank Of America Corp De has invested 0.01% in Healthcare Services Group, Inc. (NASDAQ:HCSG). Alps Advsr has 13,188 shares for 0% of their portfolio.

More recent Laboratory Corporation of America Holdings (NYSE:LH) news were published by: Businesswire.com which released: “LabCorp to Become a Preferred National Laboratory for Aetna” on May 25, 2018. Also Streetinsider.com published the news titled: “UnitedHealth Group (UNH) Announces Long-term Strategic Partnership with LabCorp (LH)” on May 24, 2018. Benzinga.com‘s news article titled: “Lab Stocks: Baird Favors Laboratory Corp., Says Quest Diagnostics Is The Simple Choice” with publication date: May 01, 2018 was also an interesting one.

Investors sentiment increased to 1.2 in 2017 Q4. Its up 0.30, from 0.9 in 2017Q3. It improved, as 36 investors sold Laboratory Corporation of America Holdings shares while 209 reduced holdings. 73 funds opened positions while 220 raised stakes. 91.47 million shares or 0.35% less from 91.79 million shares in 2017Q3 were reported. Parametric Portfolio Limited Liability holds 0.04% in Laboratory Corporation of America Holdings (NYSE:LH) or 281,597 shares. Moreover, Co Retail Bank has 0.01% invested in Laboratory Corporation of America Holdings (NYSE:LH). Hallmark Cap Mgmt holds 2.1% or 109,573 shares. Employees Retirement Association Of Colorado owns 20,151 shares. Drw Secs Lc owns 0.02% invested in Laboratory Corporation of America Holdings (NYSE:LH) for 1,416 shares. Snow Cap Lp reported 0.1% stake. Vident Invest Advisory Llc invested 0.02% of its portfolio in Laboratory Corporation of America Holdings (NYSE:LH). Proshare Limited Liability Corporation holds 0.02% or 16,286 shares in its portfolio. 1,557 were accumulated by Fulton Bankshares Na. Check Ca has invested 2.28% in Laboratory Corporation of America Holdings (NYSE:LH). 3,044 were accumulated by Howe And Rusling. Metropolitan Life Ins invested 0.03% of its portfolio in Laboratory Corporation of America Holdings (NYSE:LH). State Of Tennessee Treasury Department invested in 0.03% or 39,704 shares. Us Financial Bank De holds 0.02% or 42,069 shares. Saybrook Capital Nc has 3,200 shares.

Since February 7, 2018, it had 0 buys, and 5 selling transactions for $18.70 million activity. 8,400 shares were sold by EISENBERG GLENN A, worth $1.41M on Monday, February 12. 1,263 Laboratory Corporation of America Holdings (NYSE:LH) shares with value of $213,813 were sold by Schechter Adam H. KING DAVID P sold $8.23M worth of stock or 49,967 shares. $548,124 worth of stock was sold by ANDERSON KERRII B on Friday, February 9.

Laboratory Corporation of America Holdings operates as an independent clinical laboratory firm worldwide. The company has market cap of $18.75 billion. It operates through two divisions, LabCorp Diagnostics and Covance Drug Development. It has a 15.01 P/E ratio. The firm offers a range of clinical laboratory tests and procedures, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, PSA, tests for sexually-transmitted diseases, HCV tests, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by hospitals, physicians and other healthcare providers and commercial clients to assist in the diagnosis, monitoring and treatment of diseases and medical conditions through the examination of substances in blood, tissues, and other specimens.

Laboratory Corporation of America Holdings (NYSE:LH) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: